Amlodipine/atorvastatin fixed-dose combination: a review of its use in the prevention of cardiovascular disease and in the treatment of hypertension and dyslipidemia
K McKeage, MAA Siddiqui - American journal of cardiovascular drugs, 2008 - Springer
Amlodipine/atorvastatin (Caduet®) is a once-daily fixed-dose combination of the
dihydropyridine calcium channel antagonist amlodipine and the HMG-CoA reductase …
dihydropyridine calcium channel antagonist amlodipine and the HMG-CoA reductase …
Amlodipine/Atorvastatin: a review of its use in the treatment of hypertension and dyslipidaemia and the prevention of cardiovascular disease
MP Curran - Drugs, 2010 - Springer
Amlodipine/atorvastatin (Caduet®) is a single-tablet, fixed-dose combination of the
dihydropyridine calcium channel antagonist amlodipine and the HMG-CoA reductase …
dihydropyridine calcium channel antagonist amlodipine and the HMG-CoA reductase …
Efficacy and safety of coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia: results of the AVALON trial
FH Messerli, GL Bakris, RD Ferrera… - The Journal of …, 2006 - Wiley Online Library
The AVALON study was a randomized, multicenter trial to assess the efficacy and safety of
coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia …
coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia …
A randomized, placebo‐controlled trial to evaluate the efficacy, safety, and pharmacodynamic interaction of coadministered amlodipine and atorvastatin in 1660 …
RA Preston, P Harvey, O Herfert… - The Journal of …, 2007 - Wiley Online Library
Guidelines stress the importance of the simultaneous management of multiple
cardiovascular risk factors. This can in part be achieved by coadministration of lipid …
cardiovascular risk factors. This can in part be achieved by coadministration of lipid …
P-413: The efficacy and safety of fixed-dose combinations of amlodipine and atorvastatin in the treatment of patients with concomitant hypertension and dyslipidemia
RA Preston, P Harvey, O Herfert… - American Journal of …, 2004 - search.proquest.com
Hypertension (HTN) and dyslipidemia (DYS) commonly coexist. Patients with concurrent
HTN and DYS are at high risk of cardiovascular disease, yet most patients do not achieve …
HTN and DYS are at high risk of cardiovascular disease, yet most patients do not achieve …
Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives
M Devabhaktuni, S Bangalore - Vascular health and risk …, 2009 - Taylor & Francis
Hypertension and dyslipidemia are two of the most commonly co-occurring cardiovascular
risk factors which together cause an increase in coronary heart disease-related events that …
risk factors which together cause an increase in coronary heart disease-related events that …
Bioavailability of amlodipine besylate/atorvastatin calcium combination tablet
M Chung, A Calcagni, P Glue… - The Journal of Clinical …, 2006 - Wiley Online Library
The bioequivalence of combination tablets containing amlodipine besylate/atorvastatin
calcium with coadministered matching doses of amlodipine besylate and atorvastatin …
calcium with coadministered matching doses of amlodipine besylate and atorvastatin …
A single-pill combination of amlodipine besylate and atorvastatin calcium (update).
R Blank, FD Hobbs, J Zamorano… - Drugs of Today …, 2007 - europepmc.org
This review describes the clinical profile and rationale for the development of a single-pill
formulation of the calcium channel blocker amlodipine besylate, a blood-pressure--lowering …
formulation of the calcium channel blocker amlodipine besylate, a blood-pressure--lowering …
Amlodipine/atorvastatin: the first cross risk factor polypill for the prevention and treatment of cardiovascular disease
WH Frishman, AL Zuckerman - Expert Review of Cardiovascular …, 2004 - Taylor & Francis
In 2002, the World Health Organization estimated that over 58% of cardiovascular disease in
North America is due to 'both blood pressure and cholesterol higher than optimal' …
North America is due to 'both blood pressure and cholesterol higher than optimal' …
Fixed combination of amlodipine/atorvastatin: from mechanisms to trials
B Ivanovic, M Tadic - Journal of cardiovascular …, 2013 - journals.sagepub.com
Cardiovascular diseases are the leading cause of death worldwide. Risk factors are rarely
seen individually, and the 2 most common and most frequently associated risk factors are …
seen individually, and the 2 most common and most frequently associated risk factors are …